Company · founded 1993
Evotec (United States)
San Francisco, United States · evotec.com/articles/en/Company/10
Part of Evotec (Germany)
- Citations, last 5 years
- 342
- Works, last 5 years
- 75
- h-index
- 49
- Scientists listed
- 7
- Grants since 2016
- 6
Grants received
2025–2028 · research · Global Health
Just-Evotec Biologics, Inc. - To improve the developability and reduce the cost of goods of monoclonal antibodies to make them more affordable and accessible and prevent infecti...
Evotec (United States) · funded by Bill and Melinda Gates Foundation
2020–2025 · research · Global Health
Just-Evotec Biologics, Inc. - to enable the optimization of anti-SARS-CoV-2 mAb candidates for developability and lowest cost of goods to produce a mAb product for the preventio...
Evotec (United States) · funded by Bill and Melinda Gates Foundation
2017–2024 · research · Global Health
Just-Evotec Biologics, Inc. - to provide sequence/structure assessment and optimization of 3 candidate monoclonal antibodies, and process development and GMP manufacturing of 2 ...
Evotec (United States) · funded by Bill and Melinda Gates Foundation
2016–2018 · grant · Standard Grant
SBIR Phase I: Design, deployment, and algorithmic optimization of zoomorphic, interactive robot companions
William Knox · Evotec (United States) · funded by National Science Foundation
2015–2026 · research · Global Health
Just-Evotec Biologics, Inc. - to develop sequence optimized anti-HIV molecules that will be significantly less expensive to manufacture and have improved stability allowing for ...
Evotec (United States) · funded by Bill and Melinda Gates Foundation
2015–2020 · research · Global Health
Just-Evotec Biologics, Inc. - to develop novel technologies to lower the commercial cost of monoclonal antibodies (mAbs) for infectious diseases in low income markets
Evotec (United States) · funded by Bill and Melinda Gates Foundation